An Overview of a Year with COVID-19: What We Know?

Mirela Teodorescu

doi:10.29333/ejgm/9765

Full Text (PDF)

Mirela Teodorescu ¹ ^*

More Detail

¹ „Petru Poni” Institute of Macromolecular Chemistry, ROMANIA^* Corresponding Author

Abstract

Over the last year, SARS-CoV-2 caused the infection of more than 80 million people and about 1.8 million deaths. Since the emergence of the first cases in China, this virus has been the focal point of the scientific community and represented the main subject of a large number of research publications. It has been observed that the symptomatology is broad, varying from asymptomatic/mild manifestations to more severe stages of illness, in some cases leading to multi-organ failure and death. Although WHO announced PHEIC since January 30, and invited the researchers to quickly find solutions for diagnosis, monitoring, and treatment, there are currently no COVID-19 specific therapeutic drugs or vaccines clinically approved. This led to losses on multiple levels, such as: high number of deaths, health/financial crisis, job loss, school closures, etc. For these reasons, there is an urgent need to properly understand all aspects regarding this virus in order to successfully develop strategies to manage and stop this pandemic. Hence, this paper analysis the current knowledge and provides a comprehensive overview on this novel coronavirus.

Keywords

coronavirus
SARS-CoV-2
viral infection
genomic structure
symptoms

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Review Article

ELECTRON J GEN MED, Volume 18, Issue 3, June 2021, Article No: em286

https://doi.org/10.29333/ejgm/9765

Publication date: 07 Mar 2021

Article Views: 2655

Article Downloads: 2002

Open Access References How to cite this article

References

Tortorici MA, Veesler D. Structural insights into coronavirus entry. In: Advances in Virus Research [Internet]. Elsevier; 2019. p. 93-116. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0065352719300284
Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. 2020;94:44-8. https://doi.org/10.1016/j.ijid.2020.03.004 PMid:32171952 PMCid: PMC7102543
Chang L, Yan Y, Wang L. Coronavirus Disease 2019: coronaviruses and blood safety. Transfus Med Rev. 2020;S0887796320300146. https://doi.org/10.1016/j.tmrv.2020.02.003 PMid:32107119 PMCid:PMC7135848
Shen M, Zhou Y, Ye J, Abdullah AL-maskri AA, Kang Y, Zeng S, et al. Recent advances and perspectives of nucleic acid detection for coronavirus. J Pharm Anal. 2020;10(2):97-101. https://doi.org/10.1016/j.jpha.2020.02.010 PMid:32292623 PMCid:PMC7102540
Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10(2):102-8. https://doi.org/10.1016/j.jpha.2020.03.001 PMid:32282863 PMCid:PMC7104082
Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181-92. https://doi.org/10.1038/s41579-018-0118-9 PMid:30531947 PMCid:PMC7097006
Yang Y, Peng F, Wang R, Guan K, Jiang T, Xu G, et al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun. 2020;109:102434. https://doi.org/10.1016/j.jaut.2020.102434 PMid:32143990 PMCid:PMC7126544
Centers for Disease Control and Prevention (CDC). Revised U.S. surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases - United States and worldwide, December 2003. MMWR Morb Mortal Wkly Rep. 2003;52(49):1202-6.
Enjuanes L, Zuñiga S, Castaño-Rodriguez C, Gutierrez-Alvarez J, Canton J, Sola I. Chapter Eight - Molecular basis of coronavirus virulence and vaccine development. In: Ziebuhr J, editor. Advances in Virus Research [Internet]. Academic Press; 2016. p. 245-86. https://doi.org/10.1016/bs.aivir.2016.08.003 PMid:27712626 PMCid:PMC7112271
Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A. The Middle East Respiratory Syndrome (MERS). Infect Dis Clin North Am. 2019;33(4):891-905. https://doi.org/10.1016/j.idc.2019.08.001 PMid:31668197 PMCid:PMC7127753
Masters PS. Coronavirus genomic RNA packaging. Virology. 2019;537:198-207. https://doi.org/10.1016/j.virol.2019.08.031 PMid:31505321 PMCid:PMC7112113
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74. https://doi.org/10.1016/S0140-6736(20)30251-8
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Wang R, Zhang X, Irwin DM, Shen Y. Emergence of SARS-like coronavirus poses new challenge in China. J Infect. 2020;80(3):350-71. https://doi.org/10.1016/j.jinf.2020.01.017 PMCid:PMC7126811
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. https://doi.org/10.1038/s41586-020-2012-7 PMid:32015507 PMCid:PMC7095418
Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP. Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology. 2005;16(6):791-801. https://doi.org/10.1097/01.ede.0000181633.80269.4c PMid:16222170
Wallinga, Jacco, Teunis, Peter. Different epidemic curves for Severe Acute Respiratory Syndrome reveal similar impacts of control measures. Am J Epidemiol. 2004;160(6):509-16. https://doi.org/10.1093/aje/kwh255 PMid:15353409 PMCid:PMC7110200
Park J-E, Jung S, Kim A, Park J-E. MERS transmission and risk factors: a systematic review. BMC Public Health. 2018;18(1):574. https://doi.org/10.1186/s12889-018-5484-8 PMid:29716568 PMCid:PMC5930778
Kucharski AJ, Althaus CL. The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission. Eurosurveillance. 2015;20(25):14-8. https://doi.org/10.2807/1560-7917.ES2015.20.25.21167
Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect Dis. 2014;14(480):1-20. https://doi.org/10.1186/1471-2334-14-480 PMid:25186370 PMCid:PMC4169819
Read JM, Bridgen JR, Cummings DA, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv. 2020;2020.01.23.20018549. https://doi.org/10.1101/2020.01.23.20018549
Linka K, Peirlinck M, Kuhl E. The reproduction number of COVID-19 and its correlation with public health interventions. medRxiv. 2020;2020.05.01.20088047. https://doi.org/10.1101/2020.05.01.20088047
Gralinski EL, Menachery DV. Return of the coronavirus: 2019-nCoV. Viruses. 2020;12(135):1-8. https://doi.org/10.3390/v12020135 PMid:31991541 PMCid:PMC7077245
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. https://doi.org/10.1056/NEJMoa2001017 PMid:31978945 PMCid:PMC7092803
Li C, Yang Y, Ren L. Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species. Infect Genet Evol. 2020;82:104285. https://doi.org/10.1016/j.meegid.2020.104285 PMid:32169673 PMCid:PMC7270525
Forster P, Forster L, Renfrew C, Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A. 2020;117(17):9241-3. https://doi.org/10.1073/pnas.2004999117 PMid:32269081 PMCid:PMC7196762
Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-9. https://doi.org/10.1038/s41586-020-2008-3 PMid:32015508 PMCid:PMC7094943
Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221-36. https://doi.org/10.1080/22221751.2020.1719902 PMid:31987001 PMCid:PMC7067204
Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020;79:104212. https://doi.org/10.1016/j.meegid.2020.104212 PMid:32004758 PMCid:PMC7106301
Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92(4):424-32. https://doi.org/10.1002/jmv.25685 PMid:31981224 PMCid:PMC7166547
Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: a brief perspective from the front line. J Infect. 2020;80(4):373-7. https://doi.org/10.1016/j.jinf.2020.02.010 PMid:32109444 PMCid:PMC7102581
Kim Y, Jedrzejczak R, Maltseva NI, Endres M, Godzik A, Michalska K, et al. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. bioRxiv. 2020;2020.03.02.968388. https://doi.org/10.1101/2020.03.02.968388
Li Y-C, Bai W-Z, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552-5. https://doi.org/10.1002/jmv.25728 PMid:32104915 PMCid: PMC7228394
Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, O’Meara MJ, et al. A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. Nature. 2020;583:459-68. https://doi.org/10.1038/s41586-020-2286-9 PMid:32353859 PMCid: PMC7431030
Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: A promising cure for the global panic. Sci Total Environ. 2020;725:138277. https://doi.org/10.1016/j.scitotenv.2020.138277 PMid:32278175 PMCid:PMC7128376
Luk HKH, Li X, Fung J, Lau SKP, Woo PCY. Molecular epidemiology, evolution and phylogeny of SARS coronavirus. Infect Genet Evol. 2019;71:21-30. https://doi.org/10.1016/j.meegid.2019.03.001 PMid:30844511 PMCid:PMC7106202
Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11(1):1620. https://doi.org/10.1038/s41467-020-15562-9 PMid:32221306 PMCid:PMC7100515
Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-292.e6. https://doi.org/10.1016/j.cell.2020.02.058 PMid:32155444 PMCid:PMC7102599
Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, et al. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020;17:765-7. https://doi.org/10.1038/s41423-020-0374-2 PMid:32047258 PMCid:PMC7075278
Ou X, Zheng W, Shan Y, Mu Z, Dominguez SR, Holmes KV, et al. Identification of the fusion peptide-containing region in betacoronavirus spike glycoproteins. Perlman S, editor. J Virol. 2016;90(12):5586-600. https://doi.org/10.1128/JVI.00015-16 PMid:27030273 PMCid:PMC4886789
Millet JK, Whittaker GR. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci U S A. 2014;111(42):15214. https://doi.org/10.1073/pnas.1407087111 PMid:25288733 PMCid:PMC4210292
Bertram S, Dijkman R, Habjan M, Heurich A, Gierer S, Glowacka I, et al. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol. 2013;87(11):6150-60. https://doi.org/10.1128/JVI.03372-12 PMid:23536651 PMCid:PMC3648130
Bertram S, Glowacka I, Müller MA, Lavender H, Gnirss K, Nehlmeier I, et al. Cleavage and activation of the Severe Acute Respiratory Syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol. 2011;85(24):13363-72. https://doi.org/10.1128/JVI.05300-11 PMid:21994442 PMCid:PMC3233180
Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Krämer-Kühl A, et al. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol. 2013;87(10):5502-11. https://doi.org/10.1128/JVI.00128-13 PMid:23468491 PMCid:PMC3648152
Qian Z, Dominguez SR, Holmes KV. Role of the spike glycoprotein of human Middle East Respiratory Syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation. PloS One. 2013;8(10):e76469. https://doi.org/10.1371/journal.pone.0076469 PMid:24098509 PMCid: PMC3789674
Shirato K, Kawase M, Matsuyama S. Middle East Respiratory Syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol. 2013;87(23):12552-61. https://doi.org/10.1128/JVI.01890-13 PMid:24027332 PMCid:PMC3838146
Shirogane Y, Takeda M, Iwasaki M, Ishiguro N, Takeuchi H, Nakatsu Y, et al. Efficient multiplication of human metapneumovirus in vero cells expressing the transmembrane serine protease TMPRSS2. J Virol. 2008;82(17):8942. https://doi.org/10.1128/JVI.00676-08 PMid:18562527 PMCid:PMC2519639
Gupta MK, Vemula S, Donde R, Gouda G, Behera L, Vadde R. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J Biomol Struct Dyn. 2020;1-11. https://doi.org/10.1080/07391102.2020.1751300 PMCid:PMC7171389
Bianchi M, Benvenuto D, Giovanetti M, Angeletti S, Ciccozzi M, Pascarella S. SARS-CoV-2 envelope and membrane proteins: differences from closely related proteins linked to cross-species transmission? BioMed Res Int. 2020;2020(Article ID 4389089):1-6. https://doi.org/10.1155/2020/4389089 PMid:32596311 PMCid:PMC7261327
DeDiego ML, Álvarez E, Almazán F, Rejas MT, Lamirande E, Roberts A, et al. A Severe Acute Respiratory Syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J Virol. 2007;81(4):1701-13. https://doi.org/10.1128/JVI.01467-06 PMid:17108030 PMCid:PMC1797558
Nieto-Torres JL, DeDiego ML, Verdiá-Báguena C, Jimenez-Guardeño JM, Regla-Nava JA, Fernandez-Delgado R, et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014;10(5):e1004077-e1004077. https://doi.org/10.1371/journal.ppat.1004077 PMid:24788150 PMCid:PMC4006877
Fang X, Gao J, Zheng H, Li B, Kong L, Zhang Y, et al. The membrane protein of SARS-CoV suppresses NF-kB activation. J Med Virol. 2007;79(10):1431-9. https://doi.org/10.1002/jmv.20953 PMid:17705188 PMCid: PMC7166727
Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. 2020. https://doi.org/10.1016/j.jmii.2020.03.022 PMid:32265180 PMCid:PMC7138183
Surjit M, Lal SK. The SARS-CoV nucleocapsid protein: a protein with multifarious activities. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2008;8(4):397-405. https://doi.org/10.1016/j.meegid.2007.07.004 PMid:17881296 PMCid:PMC7106238
Chang C, Hou M-H, Chang C-F, Hsiao C-D, Huang T. The SARS coronavirus nucleocapsid protein - Forms and functions. Antiviral Res. 2014;103:39-50. https://doi.org/10.1016/j.antiviral.2013.12.009 PMid:24418573 PMCid: PMC7113676
Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325-8. https://doi.org/10.1016/j.chom.2020.02.001 PMid:32035028 PMCid:PMC7154514
Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215-20. https://doi.org/10.1038/s41586-020-2180-5 PMid:32225176
Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260-3. https://doi.org/10.1126/science.abb2507 PMid:32075877 PMCid:PMC7164637
Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444-8. https://doi.org/10.1126/science.abb2762 PMid:32132184 PMCid: PMC7164635
Glowacka I, Bertram S, Müller MA, Allen P, Soilleux E, Pfefferle S, et al. Evidence that TMPRSS2 activates the Severe Acute Respiratory Syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85(9):4122-34. https://doi.org/10.1128/JVI.02232-10 PMid:21325420 PMCid:PMC3126222
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052 PMid:32142651 PMCid:PMC7102627
Li G, Clercq ED. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19(3):149-50. https://doi.org/10.1038/d41573-020-00016-0 PMid:32127666
Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 2020;368(6489):409. https://doi.org/10.1126/science.abb3405 PMid:32198291 PMCid:PMC7164518
Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr. 2020;14(4):407-12. https://doi.org/10.1016/j.dsx.2020.04.020 PMid: 32335367 PMCid:PMC7165108
Jensen S, Thomsen AR. Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J Virol. 2012;86(6):2900-10. https://doi.org/10.1128/JVI.05738-11 PMid:22258243 PMCid:PMC3302314
Yi Y, Lagniton PNP, Ye S, Li E, Xu R-H. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020;16(10):1753-66. https://doi.org/10.7150/ijbs.45134 PMid:32226295 PMCid: PMC7098028
Mubarak A, Alturaiki W, Hemida MG. Middle East Respiratory Syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development. Quinti I, editor. J Immunol Res. 2019;2019:6491738. https://doi.org/10.1155/2019/6491738 PMid:31089478 PMCid:PMC6476043
Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020;102567-102567. https://doi.org/10.1016/j.autrev.2020.102567 PMid:32376392 PMCid: PMC7196557
Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: Immunology and treatment options. Clin Immunol. 2020;215:108448. https://doi.org/10.1016/j.clim.2020.108448 PMid:32353634 PMCid:PMC7185015
Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell. 2002;10(2):417-26. https://doi.org/10.1016/S1097-2765(02)00599-3
Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007;14(1):10-22. https://doi.org/10.1038/sj.cdd.4402038 PMid:16977329
Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38(1):1-9.
Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529-39. https://doi.org/10.1007/s00281-017-0629-x PMid:28466096 PMCid:PMC7079893
Kindler E, Thiel V, Weber F. Chapter Seven - Interaction of SARS and MERS coronaviruses with the antiviral interferon response. In: Ziebuhr J, editor. Advances in Virus Research [Internet]. Academic Press; 2016. p. 219-43. https://doi.org/10.1016/bs.aivir.2016.08.006 PMid:27712625 PMCid:PMC7112302
Lu X, Pan J, Tao J, Guo D. SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes. 2011;42(1):37-45. https://doi.org/10.1007/s11262-010-0544-x PMid:20976535 PMCid:PMC7088804
Totura AL, Baric RS. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol. 2012;2(3):264-75. https://doi.org/10.1016/j.coviro.2012.04.004 PMid:22572391 PMCid:PMC7102726
de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523-34. https://doi.org/10.1038/nrmicro.2016.81 PMid:27344959 PMCid: PMC7097822
Sun L, Xing Y, Chen X, Zheng Y, Yang Y, Nichols DB, et al. Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PloS One. 2012/02/01. 2012;7(2):e30802-e30802. https://doi.org/10.1371/journal.pone.0030802 PMid:22312431 PMCid:PMC3270028
Frieman M, Ratia K, Johnston RE, Mesecar AD, Baric RS. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kB signaling. J Virol. 2009/04/15. 2009;83(13):6689-705. https://doi.org/10.1128/JVI.02220-08 PMid:19369340 PMCid:PMC2698564
Fehr AR, Athmer J, Channappanavar R, Phillips JM, Meyerholz DK, Perlman S. The nsp3 macrodomain promotes virulence in mice with coronavirus-induced encephalitis. J Virol. 2014/11/26. 2015;89(3):1523-36. https://doi.org/10.1128/JVI.02596-14 PMid:25428866 PMCid:PMC4300739
Bouvet M, Debarnot C, Imbert I, Selisko B, Snijder EJ, Canard B, et al. In vitro reconstitution of SARS-coronavirus mRNA cap methylation. PLoS Pathog. 2010;6(4):e1000863-e1000863. https://doi.org/10.1371/journal.ppat.1000863 PMid:20421945 PMCid:PMC2858705
Chen Y, Su C, Ke M, Jin X, Xu L, Zhang Z, et al. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2’-O-methylation by nsp16/nsp10 protein complex. PLoS Pathog. 2011/10/13. 2011;7(10):e1002294-e1002294. https://doi.org/10.1371/journal.ppat.1002294 PMid:22022266 PMCid:PMC3192843
Chen Y, Cai H, Pan J, Xiang N, Tien P, Ahola T, et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc Natl Acad Sci U S A. 2009/02/10. 2009;106(9):3484-9. https://doi.org/10.1073/pnas.0808790106 PMid:19208801 PMCid:PMC2651275
Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, et al. 2’-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature. 2010;468(7322):452-6. https://doi.org/10.1038/nature09489 PMid:21085181 PMCid:PMC3058805
Züst R, Cervantes-Barragan L, Habjan M, Maier R, Neuman BW, Ziebuhr J, et al. Ribose 2’-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol. 2011/01/09. 2011;12(2):137-43. https://doi.org/10.1038/ni.1979 PMid:21217758 PMCid:PMC3182538
Siu K-L, Kok K-H, Ng M-HJ, Poon VKM, Yuen K-Y, Zheng B-J, et al. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKε complex. J Biol Chem. 2009/04/20. 2009;284(24):16202-9. https://doi.org/10.1074/jbc.M109.008227 PMid:19380580 PMCid:PMC2713514
Freundt EC, Yu L, Park E, Lenardo MJ, Xu X-N. Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein. J Virol. 2009/04/29. 2009;83(13):6631-40. https://doi.org/10.1128/JVI.00367-09 PMid:19403678 PMCid:PMC2698541
Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol. 2007/06/27. 2007;81(18):9812-24. https://doi.org/10.1128/JVI.01012-07 PMid:17596301 PMCid:PMC2045396
Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667-73. https://doi.org/10.1016/j.jiph.2020.03.019 PMid:32340833 PMCid:PMC7142680
Yoshikawa T, Hill TE, Yoshikawa N, Popov VL, Galindo CL, Garner HR, et al. Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PloS One. 2010;5(1):e8729-e8729. https://doi.org/10.1371/journal.pone.0008729 PMid:20090954 PMCid:PMC2806919
Chen J, Lau YF, Lamirande EW, Paddock CD, Bartlett JH, Zaki SR, et al. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol. 2009/11/11. 2010;84(3):1289-301. https://doi.org/10.1128/JVI.01281-09 PMid:19906920 PMCid:PMC2812346
Yao X, Li T, He Z, Ping Y, Liu H, Yu S, et al. [A pathological report of three COVID-19 cases by minimal invasive autopsies]. Zhonghua Bing Li Xue Za Zhi. 2020;49(5):411-7.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/S0140-6736(20)30211-7
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China. JAMA-J Am Med Assoc. 2020;323(11):1061-9. https://doi.org/10.1001/jama.2020.1585 PMid:32031570 PMCid: PMC7042881
Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and functional exhaustion of T cells in patients with Coronavirus Disease 2019 (COVID-19). medRxiv. 2020;2020.02.18.20024364. https://doi.org/10.1101/2020.02.18.20024364
Zheng H-Y, Zhang M, Yang C-X, Zhang N, Wang X-C, Yang X-P, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17(5):541-3. https://doi.org/10.1038/s41423-020-0401-3 PMid:32203186 PMCid:PMC7091621
Fan Y-Y, Huang Z-T, Li L, Wu M-H, Yu T, Koup RA, et al. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection. Arch Virol. 2009;154(7):1093-9. https://doi.org/10.1007/s00705-009-0409-6 PMid:19526193 PMCid:PMC2796960
Tang F, Quan Y, Xin Z-T, Wrammert J, Ma M-J, Lv H, et al. Lack of peripheral memory B cell responses in recovered patients with Severe Acute Respiratory Syndrome: a six-year follow-up study. J Immunol. 2011;186(12):7264-8. https://doi.org/10.4049/jimmunol.0903490 PMid:21576510
Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020;221(11):1762-9. https://doi.org/10.1093/infdis/jiaa150 PMCid:PMC4857467
Tynell J, Westenius V, Rönkkö E, Munster VJ, Melén K, Österlund P, et al. Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells. J Gen Virol. 2015/11/24. 2016;97(2):344-55. https://doi.org/10.1099/jgv.0.000351 PMid:26602089 PMCid:PMC4804640
Zhou J, Chu H, Li C, Wong BH-Y, Cheng Z-S, Poon VK-M, et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis. 2013/09/24. 2014;209(9):1331-42. https://doi.org/10.1093/infdis/jit504 PMid:24065148 PMCid:PMC7107356
Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87(5):e1-9. https://doi.org/10.1161/01.RES.87.5.e1PMid:10969042
Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681-7. https://doi.org/10.1038/s41591-020-0868-6 PMid:32327758
Liu Y-T, Chen H-W, Lii C-K, Jhuang J-H, Huang C-S, Li M-L, et al. A diterpenoid, 14-deoxy-11, 12-didehydroandrographolide, in andrographis paniculata reduces steatohepatitis and liver injury in mice fed a high-fat and high-cholesterol diet. Nutrients. 2020;12(2):523. https://doi.org/10.3390/nu12020523 PMid:32085637 PMCid:PMC7071475
Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020;92(6):595-601. https://doi.org/10.1002/jmv.25726 PMid:32100877 PMCid: PMC7228221
Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393. https://doi.org/10.1016/j.clim.2020.108393 PMid:32222466 PMCid:PMC7102614
Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. 2020;2020.01.26.919985. https://doi.org/10.1101/2020.01.26.919985
Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 PMid:32139904 PMCid:PMC7095524
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8. https://doi.org/10.1038/s41368-020-0074-x PMid:32094336 PMCid:PMC7039956
Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. 2020;2020.01.30.927806. https://doi.org/10.1101/2020.01.30.927806
Haga S, Yamamoto N, Nakai-Murakami C, Osawa Y, Tokunaga K, Sata T, et al. Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry. Proc Natl Acad Sci U S A. 2008;105(22):7809-14. https://doi.org/10.1073/pnas.0711241105 PMid:18490652 PMCid:PMC2409424
Mehta AK, Gracias DT, Croft M. TNF activity and T cells. TNF Fam Cytokines Recent Insights Biol Ther. 2018;101:14-8. https://doi.org/10.1016/j.cyto.2016.08.003 PMid:27531077 PMCid:PMC5305780
Cilli A, Cakin O, Aksoy E, Kargin F, Adiguzel N, Karakurt Z, et al. Acute cardiac events in severe community-acquired pneumonia: a multicenter study. Clin Respir J. 2018;12(7):2212-9. https://doi.org/10.1111/crj.12791 PMid:29570241
Corrales-Medina Vicente F., Musher Daniel M., Wells George A., Chirinos Julio A., Chen Li, Fine Michael J. Cardiac complications in patients with community-acquired pneumonia. Circulation. 2012;125(6):773-81. https://doi.org/10.1161/CIRCULATIONAHA.111.040766 PMid:22219349
Corrales-Medina VF, Suh KN, Rose G, Chirinos JA, Doucette S, Cameron DW, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med. 2011/06/28. 2011;8(6):e1001048-e1001048. https://doi.org/10.1371/journal.pmed.1001048 PMid:21738449 PMCid:PMC3125176
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Br Med J. 2020;368:m1091. https://doi.org/10.1136/bmj.m1091 PMid:32217556 PMCid:PMC7190011
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-10. https://doi.org/10.1001/jamacardio.2020.0950 PMid:32211816 PMCid:PMC7097841
Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39(7):618-25. https://doi.org/10.1111/j.1365-2362.2009.02153.x PMid:19453650 PMCid:PMC7163766
Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097-100. https://doi.org/10.1093/cvr/cvaa078 PMid:32227090 PMCid:PMC7184507
Tersalvi G, Vicenzi M, Calabretta D, Biasco L, Pedrazzini G, Winterton D. Elevated troponin in patients with Coronavirus Disease 2019: possible mechanisms. J Card Fail. 2020;S1071-9164(20)30357-2.
Patel Vaibhav B., Zhong Jiu-Chang, Grant Maria B., Oudit Gavin Y. Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Circ Res. 2016;118(8):1313-26. https://doi.org/10.1161/CIRCRESAHA.116.307708 PMid:27081112 PMCid:PMC4939482
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):1-8. https://doi.org/10.1001/jamacardio.2020.1017 PMid:32219356 PMCid:PMC7101506
Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;S0033-0620(20)30055-4. https://doi.org/10.1016/j.pcad.2020.03.001 PMid:32169400 PMCid:PMC7127395
Fan Z, Chen L, Li J, Cheng X, Yang J, Tian C, et al. Clinical features of COVID-19-related liver damage. Clin Gastroenterol Hepatol. 2020;18(7):1561-6. https://doi.org/10.1016/j.cgh.2020.04.002 PMid:32283325 PMCid: PMC7194865
Li L, Li S, Xu M, Yu P, Zheng S, Duan Z, et al. Risk factors related to hepatic injury in patients with corona virus disease 2019. medRxiv. 2020;2020.02.28.20028514.
Chau T-N, Lee K-C, Yao H, Tsang T-Y, Chow T-C, Yeung Y-C, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39(2):302-10. https://doi.org/10.1002/hep.20111 PMid:14767982 PMCid:PMC7165792
Alsaad KO, Hajeer AH, Al Balwi M, Al Moaiqel M, Al Oudah N, Al Ajlan A, et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study. Histopathology. 2018;72(3):516-24. https://doi.org/10.1111/his.13379 PMid:28858401 PMCid:PMC7165512
Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): what do we know till now? Arab J Gastroenterol. 2020;21(1):3-8. https://doi.org/10.1016/j.ajg.2020.03.002 PMid:32253172 PMCid:PMC7174834
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. https://doi.org/10.1056/NEJMoa2002032 PMid:32109013 PMCid: PMC7092819
Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2020;2020.02.03.931766. https://doi.org/10.1101/2020.02.03.931766
Zhang C, Shi L, Wang F-S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428-30. https://doi.org/10.1016/S2468-1253(20)30057-1
Strnad P, Tacke F, Koch A, Trautwein C. Liver — guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14(1):55-66. https://doi.org/10.1038/nrgastro.2016.168 PMid:27924081
Leung WK, To K, Chan PKS, Chan HLY, Wu AKL, Lee N, et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003;125(4):1011-7. https://doi.org/10.1016/j.gastro.2003.08.001
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766-73. https://doi.org/10.14309/ajg.0000000000000620 PMid:32287140 PMCid:PMC7172492
Liang W, Feng Z, Rao S, Xiao C, Xue X, Lin Z, et al. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. 2020;69(6):1141-3. https://doi.org/10.1136/gutjnl-2020-320832 PMid:32102928
Naicker S, Yang C-W, Hwang S-J, Liu B-C, Chen J-H, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020/03/07. 2020;97(5):824-8. https://doi.org/10.1016/j.kint.2020.03.001 PMid:32204907 PMCid: PMC7133222
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020/03/20. 2020;97(5):829-38. https://doi.org/10.1016/j.kint.2020.03.005 PMid:32247631 PMCid:PMC7110296
Li Z, Wu M, Yao J, Guo J, Liao X, Song S, et al. Caution on kidney dysfunctions of COVID-19 patients. medRxiv. 2020; Available at: http://europepmc.org/abstract/PPR/PPR112604
Wang Y, Zhang S, Wei Q, Zhao M, Mei H, Zhang Z, et al. COVID-19 complicated with DIC: 2 cases report and literatures review. Zhonghua Xue Ye Xue Za Zhi. 2020;41(3):245-7.
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7. https://doi.org/10.1111/jth.14768 PMid: 32073213 PMCid:PMC7166509
Subramaniam S, Scharrer I. Procoagulant activity during viral infections. Front Biosci Landmark Ed. 2018;23:1060-81. https://doi.org/10.2741/4633 PMid:28930589
Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145-8. https://doi.org/10.1016/j.cca.2020.03.022 PMid:32178975 PMCid:PMC7102663
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-9. https://doi.org/10.1111/jth.14817 PMid:32220112
Kim J-E, Heo J-H, Kim H, Song S, Park S-S, Park T-H, et al. Neurological complications during treatment of Middle East Respiratory Syndrome. J Clin Neurol. 2017;13(3):227-33. https://doi.org/10.3988/jcn.2017.13.3.227 PMid: 28748673 PMCid:PMC5532318
Tsai L-K, Hsieh S-T, Chao C-C, Chen Y-C, Lin Y-H, Chang S-C, et al. Neuromuscular disorders in Severe Acute Respiratory Syndrome. Arch Neurol. 2004;61(11):1669-73. https://doi.org/10.1001/archneur.61.11.1669 PMid:15534177
Chao CC, Tsai LK, Chiou YH, Tseng MT, Hsieh ST, Chang SC, et al. Peripheral nerve disease in SARS: report of a case. Neurology. 2003;61(12):1820-1. https://doi.org/10.1212/01.WNL.0000099171.26943.D0 PMid:14694063
Algahtani H, Subahi A, Shirah B. Neurological complications of Middle East Respiratory syndrome coronavirus: a report of two cases and review of the literature. Simone IL, editor. Case Rep Neurol Med. 2016;2016:3502683. https://doi.org/10.1155/2016/3502683 PMid:27239356 PMCid:PMC4864560
Arabi YM, Harthi A, Hussein J, Bouchama A, Johani S, Hajeer AH, et al. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection. 2015;43(4):495-501. https://doi.org/10.1007/s15010-015-0720-y PMid:25600929 PMCid:PMC4521086
Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. 2020;77:8-12. https://doi.org/10.1016/j.jocn.2020.05.017 PMid:32409215 PMCid:PMC7200361
Xia H, Lazartigues E. Angiotensin-converting enzyme 2 in the brain: properties and future directions. J Neurochem. 2008/11/05. 2008;107(6):1482-94. https://doi.org/10.1111/j.1471-4159.2008.05723.x PMid:19014390 PMCid: PMC2667944
Dubé M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018;92(17):e00404-18. https://doi.org/10.1128/JVI.00404-18 PMid:29925652 PMCid:PMC6096804
Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7. https://doi.org/10.1002/path.1570 PMid:15141377 PMCid:PMC7167720
Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995-8. https://doi.org/10.1021/acschemneuro.0c00122 PMid:32167747 PMCid: PMC7094171
Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2020;12(1):1-28. https://doi.org/10.3390/v12010014 PMid:31861926 PMCid:PMC7020001
Tu H, Tu S, Gao S, Shao A, Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J Infect. 2020;S0163-4453(20)30222-X.
Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383-4. https://doi.org/10.1016/S1474-4422(20)30109-5
Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-8. https://doi.org/10.1016/j.ijid.2020.03.062 PMid:32251791 PMCid:PMC7195378
Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv. 2020;2020.03.16.20035105. https://doi.org/10.1101/2020.03.16.20035105
Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020;76:233-5. https://doi.org/10.1016/j.jocn.2020.04.062 PMid:32312628 PMCid:PMC7158817
Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382:2574-6. https://doi.org/10.1056/NEJMc2009191 PMid:32302082 PMCid:PMC7182017
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90. https://doi.org/10.1001/jamaneurol.2020.1127 PMid:32275288 PMCid:PMC7149362
Deng Y, Liu W, Liu K, Fang Y-Y, Shang J, Zhou L, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020;133(11):1261-7. https://doi.org/10.1097/CM9.0000000000000824 PMid: 32209890 PMCid:PMC7289311
Li L, Huang T, Wang Y, Wang Z, Liang Y, Huang T, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577-83. https://doi.org/10.1002/jmv.25757 PMid:32162702 PMCid:PMC7228329
Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of Coronavirus Disease (COVID-19): encephalopathy. Cureus. 2020;12(3):e7352-e7352. https://doi.org/10.7759/cureus.7352
Okediji PT, Ojo AS, Akin-Onitolo AP. A review of the extrapulmonary manifestations of the 2019 novel coronavirus disease (COVID-19). J Contemp Stud Epidemiol Public Health. 2020 Aug 30;1(2):ep20008. https://doi.org/10.30935/jconseph/8499
Long NN, Khoi BH. An empirical study about the intention to hoard food during COVID-19 pandemic. Eurasia J Math Sci Technol Educ. 2020 Apr 24;16(7):em1857. https://doi.org/10.29333/ejmste/8207
Lounis M. Promoting school health education: A lesson from the COVID-19 pandemic. Contemp Math Sci Educ. 2020 Oct 7;1(2):ep20009. https://doi.org/10.30935/conmaths/8579
Sine H. Anxiety, depression and sleep disorders during coronavirus disease: A systematic review. Eur J Basic Med Sci. 2020 Oct 31;10(1):11-26.
Demuyakor J. Coronavirus (COVID-19) and online learning in higher institutions of education: A survey of the perceptions of Ghanaian international students in China. Online J Commun Media Technol. 2020 May 19;10(3):e202018. https://doi.org/10.29333/ojcmt/8286
Malkawi E, Bawaneh AK, Bawa’aneh MS. Campus off, education on: UAEU students’ satisfaction and attitudes towards e-Learning and virtual classes during COVID-19 pandemic. Contemp Educ Technol. 2020 Oct 14;13(1):ep283. https://doi.org/10.30935/cedtech/8708

How to cite this article

Vancouver

Teodorescu M. An Overview of a Year with COVID-19: What We Know?. ELECTRON J GEN MED. 2021;18(3):em286. https://doi.org/10.29333/ejgm/9765

APA

Teodorescu, M. (2021). An Overview of a Year with COVID-19: What We Know?. Electronic Journal of General Medicine, 18(3), em286. https://doi.org/10.29333/ejgm/9765

AMA

Teodorescu M. An Overview of a Year with COVID-19: What We Know?. ELECTRON J GEN MED. 2021;18(3), em286. https://doi.org/10.29333/ejgm/9765

Chicago

Teodorescu, Mirela. "An Overview of a Year with COVID-19: What We Know?". Electronic Journal of General Medicine 2021 18 no. 3 (2021): em286. https://doi.org/10.29333/ejgm/9765

Harvard

Teodorescu, M. (2021). An Overview of a Year with COVID-19: What We Know?. Electronic Journal of General Medicine, 18(3), em286. https://doi.org/10.29333/ejgm/9765

MLA

Teodorescu, Mirela "An Overview of a Year with COVID-19: What We Know?". Electronic Journal of General Medicine, vol. 18, no. 3, 2021, em286. https://doi.org/10.29333/ejgm/9765